SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016299
Filing Date
2023-05-11
Accepted
2023-05-11 09:00:30
Documents
75
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 888060
2 ex31-1.htm EX-31.1 19654
3 ex31-2.htm EX-31.2 20073
4 ex32-1.htm EX-32.1 8466
  Complete submission text file 0001493152-23-016299.txt   5012009

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imnn-20230331.xsd EX-101.SCH 44970
6 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imnn-20230331_cal.xml EX-101.CAL 62688
7 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imnn-20230331_def.xml EX-101.DEF 176015
8 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imnn-20230331_lab.xml EX-101.LAB 376050
9 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imnn-20230331_pre.xml EX-101.PRE 288452
69 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 575430
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 23909102
SIC: 2834 Pharmaceutical Preparations